Related Experiment Video
Updated: Jul 10, 2026

08:10
Diagnosing Pulmonary Tuberculosis with the Xpert MTB/RIF Test
Published on: April 9, 2012
Risk factors for rifampin-monoresistant tuberculosis: A case-control study
L Sandman1, N W Schluger, A L Davidow
1Division of Pulmonary and Critical Care Medicine, Department of Environmental Medicine, New York University School of Medicine, New York, USA.
American Journal of Respiratory and Critical Care Medicine
|February 2, 1999
Summary
Rifampin-monoresistant tuberculosis (RMR-TB) primarily affects individuals with prior tuberculosis (TB) history and HIV positivity. These patients often have poor outcomes, including higher mortality rates.
Area of Science:
- Infectious Diseases
- Microbiology
- Public Health
Background:
- Rifampin is a critical drug for tuberculosis (TB) treatment.
- Rifampin monoresistance (RMR) is less prevalent than other forms of drug resistance in TB.
- Identifying risk factors for RMR-TB is crucial for effective treatment strategies.
Purpose of the Study:
- To identify risk factors associated with rifampin monoresistance in tuberculosis (TB).
- To compare characteristics of patients with RMR-TB to those with drug-susceptible TB.
Main Methods:
- A retrospective case-control study was conducted.
- 21 patients with RMR-TB were compared to 48 patients with drug-susceptible TB.
- Data were analyzed controlling for year of diagnosis and HIV status.
Main Results:
- RMR-TB patients were more likely to have a history of TB (61% vs. 22%) and HIV positivity (81% vs. 46%).
- Extrapulmonary involvement (47.6% vs. 11.6%) and mortality during hospitalization (19% vs. 2.1%) were higher in RMR-TB cases.
- History of incarceration (71.4% vs. 37.5%) and malabsorption symptoms were more frequent in RMR-TB patients.
Conclusions:
- Rifampin monoresistance is strongly associated with a history of TB and HIV co-infection.
- Factors such as noncompliance, incarceration history, and malabsorption may contribute to RMR-TB.
- RMR-TB is linked to poorer patient outcomes and increased mortality.
More Related Videos
Related Concept Videos
Pulmonary Tuberculosis I
Tuberculosis, often called TB, is a contagious illness primarily caused by Mycobacterium tuberculosis. It mainly affects the lung parenchyma but can also impact other body parts.
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...
Pulmonary Tuberculosis II
Tuberculosis, or TB, is a bacterial infectious disease caused by Mycobacterium tuberculosis. While its primary impact is on the lungs, leading to pulmonary tuberculosis, it can also affect various other organs, a condition referred to as extrapulmonary tuberculosis.
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis III
Tuberculosis (TB) is a contagious infection primarily affecting the lung parenchyma but which can also affect other body parts. TB can be classified based on disease development, presentation, and the affected anatomical site.
The first classification is based on the development of the disease, and it includes the following categories:
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Tuberculosis, more commonly referred to as TB, is an infectious disease stemming from Mycobacterium tuberculosis. While it primarily impacts the lungs, TB can also affect other body areas. Given its severity and global impact, timely and accurate diagnosis is crucial for controlling its spread and improving patient outcomes.
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Pulmonary Tuberculosis V
Medical management of tuberculosis (TB) patients involves a comprehensive approach that includes diagnosis, treatment, and monitoring. The specific strategies can vary depending on the type of tuberculosis (latent or active), the patient's overall health status, and other considerations.
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the progression...
Tuberculosis
Tuberculosis (TB) remains a significant global health concern, primarily targeting the lungs and spreading through airborne transmission. Infection begins when aerosolized droplet nuclei, expelled by an individual with active TB, are inhaled by another person. These microscopic particles carry Mycobacterium tuberculosis, the causative agent of TB. Upon reaching the alveoli, the bacilli are engulfed by alveolar macrophages. However, due to their specialized lipid-rich cell wall, these pathogens...

